John W. Erickson

10.3k citations

128 papers · 8.9k · 4 hit papers · h-index 45

Impact in

Virology top 0.1%
- HIV Research and Treatment
Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Infectious Diseases 55
- HIV/AIDS drug development and treatment 50
- HIV/AIDS Research and Interventions 10
Molecular Biology 55
- Protein Structure and Dynamics 10

Co-authors: Alexander Wlodawer (4 shared papers)Sergei Gulnik (35 shared papers)Axel T. Brünger (1 shared paper)Anton E. Krukowski (1 shared paper)Michael G. Rossmann (10 shared papers)Talapady N. Bhat (16 shared papers)Dale J. Kempf (10 shared papers)Daniel W. Norbeck (8 shared papers)
Journals: Virology (11 papers)Advances in experimental medicine and biology (10 papers)Biochemistry (10 papers)Journal of Molecular Biology (6 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

John W. Erickson

126 papers receiving 8.5k citations

John W. Erickson's Hit Papers

align trajectories log scale

STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASE 1993 · 730 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1993 Annual Review of Biochemistry
1990 Acta Crystallographica Section A Foundations of Crystallography
1990 Science
1985 Nature

Peers

Countries citing papers authored by John W. Erickson

Since Specialization

Citations

This map shows the geographic impact of John W. Erickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Erickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Erickson more than expected).

Fields of papers citing papers by John W. Erickson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Erickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Erickson. The network helps show where John W. Erickson may publish in the future.

Co-authors

The 25 scholars most cited alongside John W. Erickson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John W. Erickson Line = papers co-authored together John W. Erickson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Structure of a human common cold virus and functional relationship to other picornaviruses Nature ·Michael G. Rossmann, Eddy Arnold, John W. Erickson, Elizabeth A. Frankenberger, James P. Griffith, Hans‐Jürgen Hecht, John E. Johnson, Greg Kamer, Ming Luo, Anne G. Mosser, Roland R. Rueckert, Barbara Sherry, Gerrit Vriend Hit paper breakdown →	1985	1245
2	STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASE Annual Review of Biochemistry ·Alexander Wlodawer, John W. Erickson Hit paper breakdown →	1993	730
3	Slow-cooling protocols for crystallographic refinement by simulated annealing Acta Crystallographica Section A Foundations of Crystallography ·Axel T. Brünger, Anton E. Krukowski, John W. Erickson Hit paper breakdown →	1990	502
4	Design, Activity, and 2.8 Å Crystal Structure of a C ₂ Symmetric Inhibitor Complexed to HIV-1 Protease Science ·John W. Erickson, David J. Neidhart, John H. VanDrie, Dale J. Kempf, Xiu Chun Wang, Daniel W. Norbeck, Jacob J. Plattner, Judith Rittenhouse, Mary C. Turon, Norman E. Wideburg, William E. Kohlbrenner, Robert L. Simmer, Rosalind Helfrich, Deborah A. Paul, Mark F. Knigge Hit paper breakdown →	1990	483
5	Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy AIDS ·Monique Nijhuis, Rob Schuurman, Dorien de Jong, John W. Erickson, Elena Gustchina, Jan Albert, P Schipper, Sergei Gulnik, Charles A. Boucher	1999	316
6	Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. Proceedings of the National Academy of Sciences ·Eric T. Baldwin, Talapady N. Bhat, Sergei Gulnik, M.V. Hosur, Raymond C. Sowder, Raúl E. Cachau, Jack Collins, A M Silva, John W. Erickson	1993	241
7	Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Proceedings of the National Academy of Sciences ·A M Silva, Angela Lee, Sergei Gulnik, P. Maier, Jack Collins, Talapady N. Bhat, Patrick Collins, Raúl E. Cachau, Kathryn E. Luker, Ilya Y. Gluzman, Sheila Francis, Anna Oksman, Daniel E. Goldberg, John W. Erickson	1996	239
8	Kinetic Characterization and Cross-Resistance Patterns Of HIV-1 Protease Mutants Selected under Drug Pressure Biochemistry ·Sergei Gulnik, Leonid I. Suvorov, Beishan Liu, Betty Yu, Barry Anderson, Hiroaki Mitsuya, John W. Erickson	1995	233
9	Application of the Three-Dimensional Structures of Protein Target Molecules in Structure-Based Drug Design Journal of Medicinal Chemistry ·Jonathan Greer, John W. Erickson, John J. Baldwin, Michael D. Varney	1994	216
10	Phosphorylation of Serine 392 Stabilizes the Tetramer Formation of Tumor Suppressor Protein p53 Biochemistry ·Kazuyasu Sakaguchi, Hiroshi Sakamoto, Marc S. Lewis, Carl W. Anderson, John W. Erickson, Ettore Appella, Dong Xie	1997	214
11	Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor Journal of Virology ·David D. Ho, T. TOYOSHIMA, Hongmei Mo, Dale J. Kempf, Daniel W. Norbeck, C M Chen, Norman E. Wideburg, S. K. Burt, John W. Erickson, Mohit Singh	1994	200
12	Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor Journal of Virology ·Martin Markowitz, Hongmei Mo, Dale J. Kempf, Daniel W. Norbeck, Talapady N. Bhat, John W. Erickson, David D. Ho	1995	199
13	Structural Mechanisms of HIV Drug Resistance The Annual Review of Pharmacology and Toxicology ·John W. Erickson, S. K. Burt	1996	153
14	Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease. Proceedings of the National Academy of Sciences ·Andrew H. Kaplan, Scott F. Michael, Robert S. Wehbie, Mark F. Knigge, Deborah A. Paul, Lorraine Everitt, Dale J. Kempf, Daniel W. Norbeck, John W. Erickson, R Swanstrom	1994	147
15	In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects Journal of Virology ·W J Lech, G Wang, Y L Yang, Yong Chuan Chee, Karin S. Dorman, D McCrae, Laura C. Lazzeroni, John W. Erickson, Janet S. Sinsheimer, Andrew H. Kaplan	1996	139
16	Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine Structure ·Eric T. Baldwin, Talapady N. Bhat, Sergei Gulnik, Beishan Liu, Igor A. Topol, Yoshiaki Kiso, Tsutomu Mimoto, Hiroaki Mitsuya, John W. Erickson	1995	137
17	Flap opening in HIV-1 protease simulated by ‘activated’ molecular dynamics Nature Structural & Molecular Biology ·Jack Collins, Stanley K. Burt, John W. Erickson	1995	133
18	Real‐time DNA binding measurements of the ETSl recombinant oncoproteins reveal significant kinetic differences between the p42 and p51 isoforms Protein Science ·Robert J. Fisher, Matthew J. Fivash, José R. Casas‐Finet, John W. Erickson, Akiko Kondoh, Sharon Bladen, Constance L. Fisher, Dennis K. Watson, Takis S. Papas	1994	122
19	Influence of stereochemistry on activity and binding modes for C2 symmetry-based diol inhibitors of HIV-1 protease Journal of the American Chemical Society ·M.V. Hosur, Talapady N. Bhat, Dale J. Kempf, Eric T. Baldwin, Beishan Liu, Sergei Gulnik, Norman E. Wideburg, Daniel W. Norbeck, Krzysztof Appelt, John W. Erickson	1994	122
20	Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein. Proceedings of the National Academy of Sciences ·Kazuyasu Sakaguchi, Nicola Zambrano, Eric T. Baldwin, Bruce A. Shapiro, John W. Erickson, James G. Omichinski, G. Marius Clore, Angela M. Gronenborn, Ettore Appella	1993	121

About John W. Erickson

John W. Erickson is a scholar working on Infectious Diseases, Molecular Biology, Virology, Ecology and Plant Science, having authored 128 papers that have together received 8.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (50 papers), HIV Research and Treatment (39 papers), Bacteriophages and microbial interactions (20 papers), Plant Virus Research Studies (18 papers), Click Chemistry and Applications (13 papers), Enzyme Structure and Function (10 papers), Protein Structure and Dynamics (10 papers) and HIV/AIDS Research and Interventions (10 papers). The work is most often cited by research in Virology (3.0k citations), Infectious Diseases (3.9k citations), Molecular Biology (3.7k citations), Hepatology (329 citations) and Computational Theory and Mathematics (710 citations). John W. Erickson has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Alexander Wlodawer, Sergei Gulnik, Axel T. Brünger, Anton E. Krukowski, Michael G. Rossmann, Talapady N. Bhat, Dale J. Kempf, Daniel W. Norbeck, Jack Collins and S. K. Burt. Their work appears in journals such as Virology, Advances in experimental medicine and biology, Biochemistry, Journal of Molecular Biology and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

John W. Erickson

Impact in

Papers in i

In The Last Decade

John W. Erickson

John W. Erickson's Hit Papers

Peers

Countries citing papers authored by John W. Erickson

Fields of papers citing papers by John W. Erickson

All Works

About John W. Erickson

Explore authors with similar magnitude of impact

Papers in